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Objectives: This paper aims to systematically reviewobservational studies that have analysedwhether depressive
symptoms in the community are associated with higher general hospital admissions, longer hospital stays and
increased risk of re-admission.
Methods:We identiﬁed prospective studies that looked at depressive symptoms in the community as a risk factor
for non-psychiatric general hospital admissions, length of stay or risk of re-admission. The searchwas carried out
on MEDLINE, PsycINFO, Cochrane Library Database, and followed up with contact with authors and scanning of
reference lists.
Results: Eleven studies fulﬁlled our inclusion and exclusion criteria, and all were deemed to be of moderate to
high quality. Meta-analysis of seven studies with relevant data suggested that depressive symptoms may be a
predictor of subsequent admission to a general hospital in unadjusted analyses (RR = 1.36, 95% CI: 1.28–1.44),
but ﬁndings after adjustment for confounding variables were inconsistent. The narrative synthesis also reported
depressive symptoms to be independently associated with longer length of stay, and higher re-admission risk.
Conclusions:Depressive symptoms are associatedwith a higher risk of hospitalisation, longer length of stay and a
higher re-admission risk. Someof these associationsmay bemediated by other factors, and should be explored in
more details.© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/3.0/).Introduction
One of the most common mental disorders is depression. Although
the prevalence of this disorder is reported to vary across countries
and age groups [1], its global public health implications should not
be underestimated. Depression is a primary cause of disability and
functional limitations [2], reduced quality of life [3], and mortality [4].
Depression is also associated with a number of physical conditions,titute of Psychiatry, Centre for
arch Department, PO36, David
don SE5 8AF, UK. Tel.: +44 20
.
. This is an open access article undersuch as cancer, cardiovascular diseases and diabetes, among others
[5–7].
Depressive symptomatology is extremely common among
hospitalised patients, and this has led to increasing number of studies
exploring the association between depressive symptoms and non-
psychiatric hospital admission. The majority of the literature has
however focused on clinical populations and individuals with pre-
existing co-morbid conditions, rather than on community-dwelling
people. This link has been highlighted in other reviews of clinical
populations [8], where depression was reported to be associated
with increased urgent healthcare use. It is not clear whether a relation-
ship between depressive symptoms and hospitalisation may be the
result of higher rates of physical illnesses in people with depressive
symptoms, or whether this relationship may be independent of otherthe CC BY license (http://creativecommons.org/licenses/by/3.0/).
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may be causally related to hospital admissions and outcomes, by
inﬂuencing diverse pathways. Biological mechanisms, delayed access
to care, poor treatment compliance, and direct inﬂuence on disability
have all been described as potential mechanisms [9–12]. Studying the
relationship between depressive symptoms and hospitalisation is
important, because hospital care is costly and especially so when there
are inefﬁciencies such as prolonged admissions. Health care costs are
on the increase across the world [13] and understanding determinants
of hospitalisation, length of stay and re-admission is a priority for policy
makers, in particular as healthcare costs have been reported to be
higher in people with depressive symptoms compared to thosewithout
it [14–17]. Evidence of a relationship between depressive symptoms
and hospital outcomes would further highlight the need for pre-
vention and adequate treatment of depression in the community,
especially among otherwise frail and high-risk populations, and it
may also suggest a stronger need for adequate screening for
depressed mood in hospitalised population and for a role of liaison
psychiatry.
In this review we have summarised the evidence on the relation-
ship between depressed mood in community dwelling individuals,
hospital admission and hospital outcomes. We think that this frame
of enquiry is important as it looks at the impact of depression and
patterns of hospital usage in total, and complements studies of the
impact of single disorders. The outcomes that are researched are:
non-psychiatric hospital admission, length of stay, and re-
admission. We analyse both studies that have investigated depres-
sion/depressive symptoms as a risk indicator for more or longer hos-
pital admissions, and those that aimed to unravel a causal
relationship between depression and hospital admission (i.e. adjust-
ed for potential confounders). Investigating the causal relationship
between depression and hospital admission would provide a ratio-
nale for more timely or assertive treatment of depression, hoping
to avert unnecessary hospitalisation, whereas investigating depres-
sion as an indicator of hospital admission is important in its own
right, because it would allow the identiﬁcation of high-risk individ-
uals, and would be easily measured in day-to-day clinical practice.
Aims of the study
This systematic review aims to provide a synthesis of the studies
that have investigated the association between depressed mood or
depressive symptoms, non-psychiatric hospital admission and hospital
outcomes in the population as a whole. We aimed to evaluate the
following research questions:
- Is depression or depressive symptoms associated with an increased
risk of general hospital admission, for non-psychiatric causes? Is
there still an association after adjustment for potential confounders?
- Is depression or depressive symptoms associatedwith other hospital
outcomes (i.e. length of stay and re-admission) after adjustment for
potential confounding variables?
Method
Data sources and searches
The methodology of our review followed the checklist proposed
by the Meta-analysis of Observational Studies in Epidemiology
(MOOSE) Group [18]. A literature search to explore the association
between depression/depressive symptoms, hospitalisation and related
outcomes was carried out. The search strategy included Medline,
Ovid SP, PsycINFO and the Cochrane Collaboration database. An original
search was carried out in October 2010, with further searches
to update the results conducted in July 2012, and March 2014,
with no time limits set. The search strategy conducted in Medlineused medical subject headings (MeSH) applied in the following
fashion: (“Hospitalization”[Mesh] OR “Patient Admission”[Mesh]
OR “Patient Readmission”[Mesh] OR “Length of Stay”[Mesh]) AND
(“Depression”[Mesh] OR “Depressive Disorder”[Mesh] OR “Bipolar
Disorder”[Mesh] OR “Mood Disorders”[Mesh] OR “Depressive Disorder,
Major”[Mesh]). The PsycINFO search used the following terms:
(MM “Major Depression” OR MM “Bipolar Disorder”) AND (DE
“Hospitalization” ORDE “Hospitalisation” OR DE “Hospital Admission”).
No language restrictions were applied during the title and abstract
screening; however during data extraction we further restricted our
search to English papers alone. Titles, abstracts and full-text, if available,
were screened by two separate investigators (Matthew Prina and
Martijn Huisman) using the inclusion criteria reported below. Both
investigators screened the entire sample of records, and reconciliation
was carried out at two separate stages (during the title and abstract
screening, and during the full text screening). During the full text
screening, there was agreement between the investigators in 91%
of the sample, and the remaining 9% of papers were jointly discussed
before a ﬁnal decision was made. The reference list of each paper was
also scanned to identify further studies. Throughout this text we use
the term depression, but this may be more accurately deﬁned as
depressedmood or depressive symptoms, givenour population of inter-
est. We did not restrict our selection of studies to exclude papers that
assessed depressed mood or depressive symptoms short of actual
clinical diagnoses of depression, as most of the identiﬁed studies
focused on depressive symptoms.
Inclusion and exclusion criteria
The following inclusion criteria were used to identify pertinent
papers: a) Depression or depressive symptomsmeasured before admis-
sion; b) Hospitalisation in general hospitals including emergency
departments; c) Papers including at least one of the following
outcomes: hospitalisation, length of stay, or re-admission; d) The
paper presents estimates of the association of depressive symptoms
with at least one of these outcomes. The criterion ‘a’was only applicable
to studies that investigated the relationship of depressive symptoms
with hospital admission, in order to exclude the possibility that
depressive symptoms were subsequent to hospital admission (i.e.
hospitalisation could be the cause of the depression). For the re-
admission this criterion was not applied, as depressive symptoms
would precede the outcome.
Papers were excluded if: a) they reported hospitalisation in mental
institutions, rehabilitation clinics or nursing homes; b) the primary
cause of admission was a mental disorder; c) the depressed individuals
were not analysed as a separate category; d) they focused on bipolar
disorders alone without speciﬁc mention of unipolar symptoms
(i.e. the presence or absence of symptoms of mania was the exposure
of interest); e) the study was not published in a peer-reviewed journal;
f) the participants were not living in the community; g) the ﬁndings
from the same study were already reported in another journal; and
h) the study did not focus on community-dwelling individuals but
solely on speciﬁc clinical populations (i.e. studies which focused on
people already in hospital or solely on group of individuals with pre-
existing conditions, such as asthma, stroke, and cancer).
Data extraction
A standardised data extraction form was used to collate relevant
information from each selected paper. The form included information
on setting, sample size, participants' characteristics such as age
and sex, depression scale used including cut-off point and time of
assessment. Relevant outcomes were also identiﬁed and information
regarding adjusted and unadjusted associations was extracted.
References to other potential relevant studies were also gathered at
the end of the extraction form.
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Elements of the design of identiﬁed studies were assessed by using
an adapted version of the ‘quality assessment tool for quantitative
studies’ [19]. The main components of this appraisal were: selection
bias, study design and data collection methods, withdrawals and
dropouts, type of analysis and confounders. Selection bias was assessed
by extracting information of representativeness and response rate. The
assessment of the study design was based on the sample size and by
how depressive symptoms and outcomes were measured. For each
quality metric, a score of one (‘weak’), two (‘moderate’) or three
(‘strong’) was assigned.
Data synthesis
A meta-analysis was only carried out for one outcome (hospital
admission), as there was high heterogeneity in exposure and outcome
measurements for length of stay and re-admission. A narrative synthe-
sis of these outcomes, based on the ESRC guidance on the conduct of
narrative synthesis in systematic reviews, was preferred [20].
For the main unadjusted outcome a ﬁxed-effect meta-analysis
was conducted and a pooled-estimate calculated, together with an I2
heterogeneity score [21]. A funnel-plot and a Galbraith plot based on
the Egger test [22], that plots the standard normal deviate of the
association effect against its precision, were used to assess biases in
this analysis. In order to assess whether the pooled estimate was biased
by the effect of any particular study we also carried out a sensitivity
analysis by removing one study at the time and recalculating the pooled
estimate. All the other results were synthesised in tabular format and
described in the text. Three papers [23–25] did not report unadjusted
associations and the authors were contacted for further details. Howev-
er, data were not available from the corresponding authors.
Results
Of the potential 5284 papers identiﬁed through the database searches and the
451 that were recognised via other sources (e.g. on-line reports, reference lists, up-
date searches), 11 were shortlisted. Fig. 1 shows the paper selection process, 82% of
the papers were discarded directly from reading the title and abstract, most of
which included studies relating solely to psychiatric hospitalisations. The eligibility
of 1035 papers was assessed, and full text assessment was needed for 312 papers.
Only 11 studies were carried out in the general population and fulﬁlled the other
criteria. The two main reasons for exclusion were not reporting relevant outcomes
(38%) or focusing on people with underlying cardiovascular, respiratory, diabetes
and cognitive problems (37%).
The summary characteristics of these studies are reported in Table 1. Most studies
were carried out in different countries and only the United States of America and the
Netherlands were represented in two different studies. There were a total of 33,991
individuals, with the majority of studies focusing on older age groups. One exception
was the study carried out by Koopmans and colleagues [25] which included individ-
uals aged between 15 and 90. The prevalence of depressive symptoms varied signif-
icantly across the different studies, from 4.5% in a Singaporean study to 22.4% [26]
in the study by Bula et al. [27]. This was partly due to the different cut-off points
used and the different measurement scales. Most of the studies measured depression
symptomatology using either the Geriatric Depression Scale (GDS) or the Centre for
Epidemiological Study-Depression scale (CES-D). Follow-up timeswere also different
across the studies with a range going from three months to 60 months. Ten studies
investigated ‘hospitalisation’, four ‘length of stay’, and three ‘re-admission’. The qual-
ity of the studies was moderate to high. Only one study was deemed to be using an
assessment for depressive symptoms that was too non-speciﬁc [25], which was
based on asking the respondent whether they had any complaints of stress, depres-
sion or serious nervousness in the previous ﬁve years. Outcomes on the whole were
well measured, with the exception of one paper [28], which asked the participants
retrospectively whether they had been admitted to hospital in the year before inter-
view. This measure was considered to be highly prone to recall bias. A systematic re-
view of the accuracy of self-report of hospitalisation identiﬁed common issues with
these measurements: — underreporting of visits, — over-reporting of visits in highly
distressed individuals, — misclassiﬁcation of visits in older and cognitively impaired
individuals [29]. Most of the studies did not record withdrawals during the studies,
with only two exceptions [28,30], primarily because the outcomes were tracked
using databases, and the participants were not contacted a second time. Adjustment
for potential confounders, in particular age, physical limitations and co-morbid ill-
nesses, varied across the studies and was the factor that affected the quality appraisalscores the most, with two studies carrying out poor adjustment [25,31], and one only
moderate [27]. The two studies with poor adjustment were only included in the un-
adjusted analysis that looked at depressive symptoms as a proxy for hospital admis-
sion. None of the studies included participants who had bipolar symptoms.
Hospitalisation
Most studies reported a positive association between depressive symptoms and
non-psychiatric hospitalisation before adjustment for potential confounders.
Table 2 includes a list of unadjusted risk ratios calculated from the different studies,
with an overall risk ratio for depressive symptoms of 1.36 (95% CI: 1.28–1.44)
(Fig. 2). Unadjusted data were not available from the Koopmans, Laudisio and
Rowan papers [23–25] and were therefore not included in the meta-analysis
(Fig. 2). The pooled estimate was calculated using a ﬁxed-effect model, given that
no heterogeneity was measured by the I2 test (0.00%). Using a random-effect model
did not affect the pooled-estimate (1.36, 95% CI: 1.28–1.44). The sensitivity analysis
also indicated that the no individual study had a major effect on the pooled estimate.
For example, removing Prina et al. [12] from the meta-analysis resulted in a pooled
estimate of 1.35 (95% CI: 1.23–1.48), even though the weight of this study in the orig-
inal meta-analysis was over 50%.
A funnel plot to investigate the association between standard errors and risk ra-
tios was also drawn (supplementary Fig. 1) to see whether any underlying biases
could be found in these associations. The funnel plot was symmetrical suggesting
that publication bias may not play a role in this meta-analysis. Egger's test and related
Galbraith plot (supplementary Fig. 2) were also used to investigate possible small-
study reporting bias [22]. The p value was 0.24. No evidence of publication bias was
detected but it is important to acknowledge that the power to detect such evidence
in this setting was extremely low.
The role of potential confounders was investigated by most authors, with the
exception of one study [31]. The degree of modelling varied across the studies, but
most studies adjusted for co-morbidity and socio-demographics. The highest unad-
justed relative risk (RR = 1.95,95% CI: 1.47–2.58) was reported by Huang and col-
leagues [32], for men and women combined. However, after full adjustment the
association they reported remained statistically signiﬁcant only among men aged
75 and over (RR = 3.43, 95% CI: 1.33–8.9). Of the other seven studies, four reported
an independent effect of depressive symptoms on hospitalisation [12,23,24,30],
whereas the other four [25,26,28,33] reported wide 95% CI conﬁdence intervals
after adjustment for potential confounders (Table 3).
Only one study [12] sub-divided depressive symptoms by increasing severity,
reporting increasing hazard ratios for increasing scores on the geriatric depression
scale. The adjusted HR for questionable depression (GDS scores: 1 to 4) were 1.70
(95% CI: 1.50–1.92), for mild to moderate depression (GDS scores: 5–9) 2.08 (95%
CI: 1.68–2.58) and for severe depression 3.06 (2.10–4.46), compared with patients
with no depression.
Other outcomes
The other outcomes of interest that were reported in these studies are presented
in Table 3. The associations reported in this table are for the fully adjusted models,
and are therefore measuring the independent effect of depressive symptoms on
these outcomes (i.e. independent of demographic factors and comorbidity or chronic
disease severity).
Four studies investigated length of stay, and all reported a positive association
between depressive symptoms and length of stay in hospital (Table 3). The duration
of hospital admissions was measured differently in the different databases, hindering
any further analysis on the data. Wong [30] grouped the number of days spent in hos-
pital in zero, one to ﬁve, six to 15 and more than 16, whereas Rowan [24] used a di-
chotomous variable comparing individuals who spent more than three days in
hospital with those who spent less than three. The two papers from Prina and col-
leagues [33,12] used mean and median length of stay to explore the relationship.
The RR of increased duration of admission for individuals with depression ranged
from 1.1 to 1.9 (Table 3).
Re-admission was reported in three studies. One used a dichotomous approach
(re-admitted vs non re-admitted) and the other two used a continuous variable re-
cording the number of hospitalisations. All the three studies reported positive associ-
ations in their multivariate models (Table 3). Bula et al. [27] reported the highest
increased risk of hospital re-admission (adjusted HR = 1.50, 95% CI: 1.03–2.17),
and both Prina [12] and Wong [30] found that depressive symptoms were associated
with increased number of re-hospitalisations. A further study that our group carried
out in the Dutch population [33] did not ﬁnd any signiﬁcant differences in the number
of hospitalisations after adjustment for confounding variables (adjusted HR = 1.02,
95% C: 0.84–1.23).
Discussion
The purpose of this paper was to give a comprehensive review of
the literature regarding the association between depressive symp-
toms, non-psychiatric hospitalisations and related outcomes. Most
studies of the relationship between hospitalisation and depressive
Fig. 1. Study selection process. *Includes animal studies and studies relating only to psychiatric hospitalisation.+ Includes 367 from updated searches and 84 extra references from other
papers. $ studies identiﬁed from additional searches.
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therefore excluded from this synthesis, whereas only a small per-
centage of studies was carried out in the general population of adults
living in the community. Most of these latter studies reported an as-
sociation between depressive symptoms, hospital admission, length
of stay and number of re-admissions. Meta-analysis revealed depres-
sive symptoms to be a potential indicator of subsequent
hospitalisation RR = 1.36 (95% CI: 1.28–1.44), but the literature re-
ported mixed ﬁndings on this relationship after adjustment for po-
tential confounders. Depressive mood was also reported to be
independently associated with longer length of stay with risk ratios
varying from 1.1 to 1.9, and re-admission (lowest RR= 1.02, highest
RR = 1.5).
Limitations
Although it is possible that some papers were missed using the
search strategy of this study, checking the reference list of each
paper will have enhanced the sensitivity of our search. Therefore
we believe that this possibility of missing relevant papers has been
mitigated as far as possible.
The search was not originally limited to papers written in English.
However, due to problems with accessibility and translation, one
Japanese paper was excluded in the ﬁnal selection screening [34]. We
were therefore unable to assess whether this paper was relevant.
The meta-analysis only included seven (out of ten) studies that
assessed depressive symptoms and hospitalisation. Although no biaseswere found using the Egger method, the power needed to detect any
bias was probably low, given the small number of studies.
Several studies of patients in hospital were excluded because they
did not identify depressive symptoms before admission [13,35–40].
This choice was dictated by wanting to analyse a prospective relation-
ship, and not depressive symptoms driven by the admission itself.
However, we cannot completely rule out the possibility that existing
depressive symptoms in a number of individuals were the results of
prior hospitalisations that were not recorded at the beginning of these
studies. It has to be acknowledged that the inverse relationship (i.e.
admission driving depression) is also an important one that needs to
be further assessed by future studies.
All the studies measured depressive symptoms rather than major
depressive disorder, and did not try to fully assess the severity of
depressive symptoms. The risk to individuals suffering with major
depressive disorder is probably higher than the risk carried by elevated
scores on symptom rating scales such as the CES-D and GDS. One study
[12] showed that the hazard ratios for hospitalisation were higher in
patients with more severe depression, suggesting that the associations
found in the literature are likely to be underestimates of the real link
between major depression and medical admission. Using different
scales for depressive symptoms, such as GDS, CES-D or BDI-II may also
affect the risk estimates for hospitalisation. However, we could not see
any signiﬁcant differences in estimates between studies that used the
GDS versus those that used the CES-D.
Finally, we were unable to differentiate between emergency
admissions and inpatient hospital admissions, as themajority of studies
Table 1
Summary characteristics of included studies investigating depression and hospitalisation in the community. dep = depressive symptoms, nodep = no depressive symptoms, GDS = Geriatric Depression Scale, CES-D = Center for Epidemiologic
Studies Depression Scale Revised.
Authors, year Country and
sample size
Disease focus Age Depression
measure
Depression
prevalence
Follow-up time Outcomes Control for other variables
Hospitalisation Length of
stay
Re-admission
Bula et al., 2001 [27] Switzerland
n = 401
General but with previous
hospitalisation
75+ GDS 22.4% 6 months x Age, gender, living alone,
education, income, previous
admission, co-morbidities,
functional limitations.
Callahan et al., 1997 [31] USA
n = 3767
General population Mean: dep
66.6
nodep 68.1
CES-D 16.2% 12 months x n/a
Feng et al., 2009 [26] Singapore
n = 973
General population 55+ GDS 4.9% 12 months x Age, gender, education, ethnicity,
housing type, social-emotional
support,
co-morbidities, self-rated physical
health, disability, cognitive
impairment.
Huang et al., 2000 [32] USA
n = 3486
General population 65+ CES-D 8.9% 6 months x Age, gender, marital status, income,
level of education, urbanicity,
co-morbidities, cognitive functions,
number of medications
Koopmans et al., 2006 [25] Netherlands
n = 8698
General but with previous
hospitalisation
Range: 15–90 Self-report 12.2% 12 months x Age, gender, living alone, education,
marital status, co-morbidities
Larsen et al., 2006 [28] Denmark
n = 406
General population Mean: 75 CES-D 16% men
30% women
60 months x Gender, living alone, self-rated
health, previous hospitalisation
Laudisio et al., 2010 [23] Italy
n = 344
General population Mean: dep 80
nodep 79
GDS 51% 12 months x Age, gender, previous
hospitalisation, white blood cell
count, medications
Prina et al., 2012 [33] Netherlands
n = 3304
General population 55+ CES-D 16% 24 months x x x Age, gender, education,
co-morbidities, functional
limitations, smoking, alcohol
problems
Prina et al. 2013 [12] Australia
n = 5411
General population Mean: 78.6 GDS 6.3% 24 months x x x Age, education level, social support,
Rowan et al. 2002 [24] Canada
n = 3227
General population Mean: dep 45
nodep 48
CES-D n/a 12 months x x co-morbidities, smoking
Wong et al. 2009 [30] China
n = 3770
General population 65+ GDS 9.9% n/a x x x Age, gender, disease severity,
co-morbidities
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Table 2
Absolute numbers of people hospitalised according to their depression status, and Risk Ratio (RR) with 95% Conﬁdence Interval (CI). 1 Numbers based on overnight admissions alone.
Depressed Non-depressed RR 95% CI
Hospitalised Not hospitalised Hospitalised Not hospitalised
Callahan [31] 137 475 536 2619 1.32 (1.12–1.56)
Feng [26] 6 42 68 857 1.70 (0.78–3.72)
Huang [32] n/a n/a n/a n/a 1.95 (1.47–2.58)
Koopmans [25] n/a n/a n/a n/a n/a n/a
Larsen [28] 32 65 65 244 1.57 (1.10–2.24)
Laudisio [23] n/a n/a n/a n/a n/a n/a
Prina, 2012 [33] 177 1131 722 6252 1.31 (1.12–1.52)
Prina, 2013 [12] 197 86 2054 1975 1.37 (1.26–1.48)
Rowan [24] n/a n/a n/a n/a n/a n/a
Wong [30] 81 171 681 2049 1.29 (1.06–1.56)
30 A.M. Prina et al. / Journal of Psychosomatic Research 78 (2015) 25–33did not report separate ﬁgures for diverse types of hospital admission.
However, we are conﬁdent that all the events severe enough to require
hospitalisation would have been captured regardless of whether the
initial admission was in an emergency department.
Interpretation of ﬁndings
Most studies in the general population reported a positive associ-
ation between depressive symptoms and hospital admission, indi-
cating that depressive symptoms are a risk indicator for future
hospital admissions. These associations remained statistically signif-
icant in only half of the studies. The studies that did not ﬁnd statisti-
cally signiﬁcant associations were characterised by several potential
limitations. Koopmans et al. [25] used a partially validated [41] as-
sessment for depression, which measured self-reported depressive
complaints, whereas Larsen [28] used an extremely long follow-up
time of 5 years. Finally, it is possible that in our own previous study
[33] we over-adjusted our statistical analysis. In this paper, a sepa-
rate model was ﬁtted for each factor, and it was found that adjusting
for functional limitations consistently had the biggest impact on
odds ratios. It is also worth noting that age and gender are likely to
be true confounders, whereas functional limitations may be a medi-
ator of this association. Unfortunately this hypothesis was not tested
in any of the papers. Positive associations after adjustment for con-
founders were reported for both length of stay and for re-
admission in all the studies, but were not heterogeneous for hospitalFig. 2. Fixed meta-analysis with pooled estimate of studies investigating the associatadmission. Most studies were conducted among older people. Phys-
ical illness and disability are the two of the most important risk fac-
tors for late life depression and older depressed people without
physical illness or disability are a small minority [42]. Any attempt
to disentangle the effects of depression and physical illness/disabili-
ty in a naturalistic study is likely to fail because both depressive
symptoms and physical illnesses are likely to be chronic or intermit-
tent. This further hinders drawing a clear line between their respec-
tive impact in causing hospital admission. If it is true that depressive
symptoms do not increase medical hospitalisation in the absence of
medical co-morbidity, adjusting for physical comorbidity becomes
important, as it suggests that any association of depression with hos-
pital admission is due to underlying medical conditions. However, it
is also possible that depressive symptoms may exacerbate medical
symptoms or increase use of primary care services, and thus increase
the risk of hospitalisation in people with existingmedical conditions.
One of the major problems in comparing the studies was the highly
variable follow-up periods. This could have affected the associations, as
shown by Prina et al. [33], where the magnitude of the associations
varied when different follow-up times were used. This is a common
problem in longitudinal research on depression. Most of these studies
only measured depressive symptoms at baseline, and never again
during the course of the study. The average duration of an untreated
episode of depression has been described to be around six to eight
months with almost 50% of individuals relapsing within a 5 year
period [43]. It is difﬁcult to say whether misclassiﬁcation bias couldion of depressive symptoms with hospital admission in the general population.
31A.M. Prina et al. / Journal of Psychosomatic Research 78 (2015) 25–33play a role in all of these studies as the episodic nature of depressive
symptoms could have been resolved before hospitalisation, but it is
likely to have played a stronger role in those studies that had a longer
follow-up, in particular without having information on concurrent
treatment and medication use. With longer follow-ups, we expect
the effect of depression at baseline to become diluted, and with thor-
ough treatment of depressive symptoms, the effect of depression
should be ameliorated over time. This observation is somewhat sup-
ported by this review, which reported a neutral association by the
study [28] with the longest follow-up time. Seven studies had a
follow-up period above 12 months, suggesting that the overall esti-
mate could be biased towards the null.
The relationship between hospitalisation and depressive symp-
toms could be explained by poor treatment adherence that is com-
mon in people suffering with mood disorders and that could
translate into worsening of symptoms and hospitalisation for an un-
derlying physical disorder [9,44]. Poorer clinical prognoses at admis-
sion, partly driven by the direct inﬂuence of depressive symptoms on
the hypothalamic–pituitary–adrenal axis, the immune system, and
the sympathetic nervous system, could also explain longer length
of stays and risk of re-admission in people with depression [45]. Ef-
fective communication with health professional could also be affect-
ed in people with depressed mood. This could lead to a delay in a
diagnosis and treatment [12]. Depressive symptoms may also impair
a person's motivation towards recovery and their response to
rehabilitation.Table 3
Outcomes in the general population. All the associations reported are adjusted. The exact adju
presented only adjusted for age and gender, the full analysis was only reported after stratiﬁc
for overnight admission alone).
Hospitalisation Length of stay
Follow-up time Direction of association Measurement
Bula [27] – – –
Feng [26] 12 months Neutral
HR = 1.06
(95% CI:
0.44–2.58)
Huang [32] 6 months Positive
RR1 = 2.25
(95% CI: 1.50–3.40)
Koopmans [25] 12 months Neutral
Β2 = 0.022 (p N 0.05)
–
Larsen [28] 60 months Neutral
OR = 1.3
(95% CI:
0.5–3.3)
–
Laudisio [23] 12 months Positive
RR = 1.05
(95% CI: 1.01–1.09)
Prina-2012 [33] 12 months Neutral
OR = 1.01
(95% CI:
0.83–1.22)
Mean total length of stay
(continuous)
Prina-2013 [12] 24 months Positive
HR = 1.673
(95% CI: 1.38–2.01)
Mean and total length of st
(continuous)
Rowan [24] 12 months Positive
OR = 1.5
(95% CI: 1.1–2.0)
Number of days in hospital
(dichotomous)
Wong [30] – – Number of days in hospital
(categorical)Future implications
This review suggests that there is a link between depressive
symptoms, hospitalisation and hospital-related outcomes. It is likely
that this association is mediated by other factors and that depressive
symptoms are not the sole independent factor in this relationship,
even though most studies reported positive associations after
adjustment for potential confounders. The majority of the studies we
identiﬁed were conducted in older adults, who often have physical co-
morbidities, and we believe it would be important to carry out more
studies in younger patients with fewer somatic diseases in order to
disentangle the bidirectional association between depression and
physical co-morbidities. What transpires from this review, however, is
that depression is a good predictive proxy for hospital outcomes.
Further research with larger sample sizes, better assessment of depres-
sion (i.e. full clinical interviews and severity) and outcomes is needed, if
potential pathways explaining this association are to be described in
greater detail. Ideally this should be from a population-based sample
rather than a clinic based one, to avoid the further biases of the latter.
Insight can be gained from large-scale observation studieswith rigorous
assessment of depression and careful selection of confounders, which
present results of unadjusted, partially adjusted and fully adjusted
models. This unfortunately would require a large amount of resources.
We advocate for the use of underutilised available resources, including
linkage of cohort studies with clinical data. A number of health systems
across theworld collect routine clinical data, but these are often difﬁcultstments are reported in Table 1. 1Coefﬁcient from a binomial regression analysis. 2 Data
ation by age and gender. 3 Adjusted analyses only available for any admissions (and no
Re-admission
Direction of association Measurement Direction of association
– Dichotomous Positive
HR = 1.5
(95% CI:
1.0–2.2)
– – –
– – –
Positive
OR = 1.3
(95% CI:
1.2–1.5)
Number of hospitalisations
(continuous)
Neutral
OR = 1.02
(95% CI:
0.84–1.23)
ay Positive
RR = 1.9 (95% CI:
1.6–2.2)
Number of hospitalisations
(continuous)
Positive
RR = 1.5
(95% CI:
1.3–1.7)
Positive
OR = 1.8
(95% CI:
1.1–3.0)
– –
Positive
RR = 1.1 (95% CI:
1.0–1.2)
Number of hospitalisations
(categorical)
Positive
RR = 1.3
(95% CI:
1.1–1.4)t
32 A.M. Prina et al. / Journal of Psychosomatic Research 78 (2015) 25–33or impossible to access due to strict regulations. It is important that
these resources are made available to the wider scientiﬁc community,
while respecting ethical and privacy norms. Moreover it is important
to look atwhat happens to the level of hospital admission in experimen-
tal designs, collating data from RCTs and prospective follow-up patients
with regard to their admission. In countries with good registration
bases, this should be possible. Following such studies it might be
possible to identify particular groups at higher risk and investigate
whether targeted interventions in multiple health domains reduce
these possible adverse consequences. Some encouraging results
have been presented by Lin and colleagues [46], who showed that by
improving depression care in a group of older adults with arthritis,
functional outcomes and pain were also improved. Another trial
showed that mortality risk in depressed patients could be lowered
using a depression care management intervention [47]. It is not
known whether this could be translated and used for reducing hospital
admissions and length of stay, but it should be explored as a potential
avenue of reducing hospital admissions, lengths of stay and, in the
longer term, healthcare costs.
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